Sandra Levy
ARTICLES BY THIS AUTHOR
- 2/10/2021
IQVIA’s Long offers view of pharmaceutical industry amid COVID pandemic
IQVIA's Doug Long weighed in on the pharmaceutical market amid COVID-19 during a DSN webinar held Thursday. - 2/10/2021
McKesson RxOwnership expands Pharmacy Ownership Workshop series
McKesson RxOwnership signed a new five-year commitment with the National Community Pharmacists Association to sponsor the Pharmacy Ownership Workshop series. - 2/9/2021
Glenmark obtains FDA green light for generic Qudexy
Qudexy XR capsules had a market value of about $120.8 million for the 12 month period endedDecember 2020, according to IQVIA. - 2/9/2021
Regeneron, Sanofi get FDA nod for new indication for Libtayo
Libtayo is now approved for both advanced cutaneous squamous cell and basal cell carcinomas. - 2/9/2021
APhA names Shannon Morrison CFO
Shannon Morrison, succeeds Joe Janela as CFO, who is retiring after 11 years at APhA. - 2/8/2021
Virtual roundtable: State of the generics industry
Executives from leading generics firms weigh in on what the future holds for the industry and what hurdles will have to be overcome. - 2/8/2021
Lupin gets FDA nod for generic Kerydin
Tavaborole topical solution had a market value of roughly $76 million, according to IQVIA December 2020 data. - 2/8/2021
Lannett expands strategic relationship with HEC for biosimilar Aspart
Lannett and HEC will co-develop biosimilar insulin Aspart, with Lannett possessing exclusive U.S. commercialization rights. - 2/8/2021
APhA Foundation awards student scholarships
Nineteen pharmacy students have been awarded the 2021 American Pharmacists Association Foundation Student Scholarship based on their academic achievements and leadership skills. - 2/8/2021
Alembic debuts generic Symmetrel
Alembic's generic Symmetrel is available in a dosage strength of 100 mg in 100-count bottles.
